BridgeMD
Tests treatment safety and results for Overactive Bladder
Official title Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
ClinicalTrials.gov ID: NCT05997992
What this study is testing
- What it's testing
- Overactive bladder (OAB) is often accompanied by frequent urination and nocturia, and does not necessarily manifest as urge incontinence. Urgency to urinate and frequent urination can lead to psychological burdens, affect interpersonal relationships and reduce women's quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80, women only
You may be able to join if
- Female patient aged 20-80 with overactive bladder.
You likely can't join if
- Patient has history of cancer, stroke, or hyperthyroidism..
- Patient isn't willing to accept acupuncture or moxibustion treatment.
- Patient who is pregnant or plan to pregnant.
- Patient with urinary tract infection.
- Patient who had injection of botulinum toxin (Botox®), PTNS or SMN treatment before.
- Patient recieved acupuncture treatment before.
The study team makes the final eligibility decision.
Where it's taking place
- New Taipei City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Taipei City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.